他汀类药物可降低老年2型糖尿病患者的谵妄风险
这项回顾性队列研究基于台湾全民健康保险研究数据库(2008-2021),纳入110,090例≥65岁2型糖尿病患者,经倾向评分匹配后比较他汀使用者与非使用者。结果显示他汀使用显著降低谵妄风险(aHR 0.73,95%CI 0.67-0.79,P<.0001),亲水性他汀保护作用更强,且累积剂量越高风险降低越明显。
要点
- 他汀使用与老年2型糖尿病患者谵妄风险显著降低相关(aHR 0.73)。
- 亲水性他汀保护作用优于亲脂性他汀(aHR 0.67 vs 0.76)。
- 累积剂量最高四分位者谵妄风险降低最显著(aHR 0.36)。
核心结论
- 他汀类药物,尤其是亲水性他汀和较高剂量,可显著降低老年2型糖尿病患者的谵妄风险。
研究设计与样本
- 回顾性队列研究,使用倾向评分匹配和Cox回归分析,并进行竞争风险分析以考虑死亡。
- 共纳入110,090例≥65岁2型糖尿病患者,包括55,045例他汀使用者和55,045例匹配的非使用者。
主要发现
- 他汀使用显著降低谵妄风险(aHR 0.73,95%CI 0.67-0.79,P<.0001)。
- 亲水性他汀保护作用更强(aHR 0.67,95%CI 0.59-0.76),亲脂性他汀aHR为0.76(95%CI 0.69-0.82)。
- 累积剂量越高风险降低越明显,最高剂量四分位(Q4)aHR为0.36(95%CI 0.30-0.43)。
- 发病率比值(IRR)为0.70(95%CI 0.65-0.76,P<.0001)。
临床怎么用
- 对于老年2型糖尿病患者,可考虑使用他汀类药物以降低谵妄风险,亲水性他汀和较高累积剂量可能带来更大获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the impact of statins on delirium incidence in older adults with type 2 diabetes mellitus (T2DM), focusing on hydrophilic versus lipophilic statins and dose-response effects. DESIGN: Retrospective cohort study using propensity score matching and Cox regression analysis, with competing risk analysis to account for mortality. SETTING AND PARTICIPANTS: A total of 110,090 older adults (aged ≥65 years) with type 2 diabetes mellitus identified from Taiwan's National Health Insurance Research Database (2008-2021), including 55,045 statin users and 55,045 matched non-users. METHODS: Delirium incidence was compared between statin users and non-users, adjusting for potential confounders. Analyses evaluated the differential effects of hydrophilic and lipophilic statins and assessed the dose-response relationship using cumulative daily doses. RESULTS: Statin use significantly reduced delirium risk [adjusted hazard ratio (aHR), 0.73; 95% confidence interval (CI), 0.67-0.79; P < .0001]. Hydrophilic statins showed greater protection (aHR, 0.67; 95% CI, 0.59-0.76) compared with lipophilic statins (aHR, 0.76; 95% CI, 0.69-0.82). Higher cumulative doses were associated with greater risk reductions, with the highest dose quartile (Q4) demonstrating an aHR of 0.36 (95% CI, 0.30-0.43). The incidence rate ratio (IRR) was 0.70 (95% CI, 0.65-0.76; P < .0001). CONCLUSIONS AND IMPLICATIONS: Statins, particularly hydrophilic types and higher doses, significantly reduce delirium risk in older adults with type 2 diabetes mellitus. These findings support statins' role in mitigating cognitive decline and improving outcomes in this population, with implications for clinical practice and future research.
引用
- Sun M, Wang X, Lu Z, et al. Statins Reduce Delirium Risk in Older Adults With Type 2 Diabetes. J Am Med Dir Assoc. 2025. PMID: 39952282. doi:10.1016/j.jamda.2025.105490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。